| P2093 | author name string | Gerhard Winter | |
| | Katharina J Geh | |
| | Madlen Hubert | |
| P2860 | cites work | Use of alternative animals as asthma models | Q37184854 |
| | Mesoporous silica nanoparticles for intracellular controlled drug delivery. | Q37778327 |
| | Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. | Q38149686 |
| | Recurrent airway obstruction: a review | Q38155919 |
| | A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses. | Q39657008 |
| | Transglutaminase: New insights into gelatin nanoparticle cross-linking | Q39822726 |
| | Recombinant human gelatin nanoparticles as a protein drug carrier | Q40004384 |
| | Collagen crosslinking of human and porcine sclera | Q40521552 |
| | Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery | Q43085015 |
| | Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles | Q44798368 |
| | Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. | Q45956342 |
| | Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles | Q46517065 |
| | Equilibrium cluster formation in concentrated protein solutions and colloids | Q59063283 |
| | Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system | Q27004381 |
| | Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin). | Q31891715 |
| | Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. | Q33217285 |
| | Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures | Q34208512 |
| | Gelatin as a delivery vehicle for the controlled release of bioactive molecules | Q34464776 |
| | In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs - a pilot study | Q34798245 |
| | Recurrent airway obstruction--heaves | Q35127841 |
| | Protamine and protamine reactions | Q35810012 |
| | Therapeutic potential of Toll-like receptor 9 activation | Q36501229 |
| | Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study. | Q36873614 |
| P433 | issue | 7 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 595-604 | |
| P577 | publication date | 2016-08-24 | |
| P1433 | published in | Journal of Microencapsulation | Q15708887 |
| P1476 | title | Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production | |
| P478 | volume | 33 | |